Patient Blood Management Market to Record USD 34.1 Billion by 2036, Featuring Haemonetics, Terumo and Fresenius Kabi
The global patient
blood management market is projected to increase from USD 17.0 billion in
2026 to USD 34.1 billion by 2036, registering a compound annual growth rate
(CAGR) of 7.2%, according to Fact.MR. The market was valued at USD 15.9 billion
in 2025. Growing attention to safe transfusion practices, avoidable blood loss
reduction, and effective blood-use decisions is encouraging hospitals to adopt
patient blood management (PBM) systems and protocols.
Patient blood management combines clinical practices,
instruments, software, and hospital workflows to optimize the use of a
patient's own blood. Its scope includes anemia management, surgical blood
conservation, transfusion decision support, cell salvage, and blood inventory
control. Adoption requires coordination among surgeons, anesthesiologists,
laboratory teams, nurses, and hospital blood banks.
Get detailed market
forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=7783
Instruments Lead Product-Type Demand
Instruments are projected to account for 41.0% of the
patient blood management market in 2026, making them the leading product
category. Hospitals use these systems for blood processing, cell salvage, and
transfusion support across operating rooms, blood banks, and critical care
settings. Accessories, reagents and kits, and software also contribute to the
market, with digital solutions supporting inventory visibility and transfusion
audits.
By management area, blood transfusion management is expected
to hold a 38.0% share in 2026. This reflects hospitals' focus on appropriate
blood-use decisions, patient safety, and clinical documentation.
Perioperative care is projected to represent 36.0% of the
market by application, as surgical procedures create demand for anemia
screening, blood conservation tools, and transfusion protocols. Hospitals are
expected to remain the leading end-user segment with a 49.0% share, while
direct institutional sales are forecast to account for 53.0% of the market.
Regional Outlook: India Leads Country Growth
India is projected to record the fastest growth among the
countries covered, with a CAGR of 8.4% through 2036. Hospital expansion and
rising surgical demand are supporting the adoption of blood conservation
systems and transfusion decision support.
China follows with a projected CAGR of 8.1%, supported by
healthcare infrastructure development and blood safety modernization. Canada is
forecast to grow at 6.9%, while the United States is expected to register 6.8%.
Germany and Japan are projected to expand at CAGRs of 6.2% and 5.8%,
respectively. Brazil is forecast to record a CAGR of 5.6% over the assessment
period.
Analyst Perspective
Shambhu Nath Jha, Senior Analyst at Fact.MR, notes, “Patient
blood management is becoming a hospital quality program rather than a blood
bank initiative alone. Hospitals will gain when anemia screening, cell salvage,
transfusion decision support, and blood inventory control work as one clinical
system. Suppliers that support workflow integration and clinical training will
be better placed.”
The report identifies implementation complexity as a key
market restraint. Successful PBM adoption requires coordination across clinical
departments, staff training, and integration with hospital workflows. Suppliers
offering implementation support, clinical education, and software capabilities
can address these operational requirements.
Competitive Landscape
The patient blood management market includes medical
technology companies, blood processing specialists, diagnostics providers, and
software suppliers. Key companies profiled by Fact.MR include Haemonetics
Corporation, Terumo Blood and Cell Technologies, Fresenius Kabi, Grifols S.A.,
Immucor, Inc., Macopharma, Werfen, Cerus Corporation, B. Braun Melsungen AG,
Bio-Rad Laboratories, Inc., Roche Diagnostics, Quotient Limited, Medtronic plc,
and Stryker Corporation.
Competition is shaped by instrument reliability, transfusion
traceability, software functionality, hospital-system integration, and clinical
training support. Providers that address multiple stages of blood management
workflows are positioned to serve hospitals seeking coordinated PBM programs.
Market Snapshot
- Market
size (2025): USD 15.9 billion
- Estimated
market size (2026): USD 17.0 billion
- Forecast
market size (2036): USD 34.1 billion
- CAGR
(2026–2036): 7.2%
- Leading
product type: Instruments (41.0% share in 2026)
- Leading
management area: Blood transfusion management (38.0%)
- Leading
application: Perioperative care (36.0%)
- Leading
end user: Hospitals (49.0%)
- Leading
sales channel: Direct institutional sales (53.0%)
- Fastest-growing
country: India (8.4% CAGR)
To View Related
Reports
https://afgbfh.blogspot.com/2026/10/surgical-site-infection-control-market.html
About Fact.MR
Fact.MR is a market research and competitive intelligence
provider delivering market intelligence, competitive analysis, and forecasting
across global industries. Its research helps businesses evaluate market demand,
understand competitive developments, and identify growth opportunities.